Clin2
NCT07736963Possibly a fitRecruiting

Stopping GLP-1 drugs before colonoscopy: a trial in Taiwan

GLP-1

Part of Digestive system, Hormones & metabolism clinical trials.

This study looks at whether stopping GLP-1 receptor agonists (a type of diabetes or weight-loss medication) before a colonoscopy can help improve the procedure. It compares how well the bowel is cleaned in people who stop these drugs for a certain time versus those who continue them.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
240 people
Ages
18 years to 90 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old.
  • You are scheduled for a full colonoscopy for any reason.
  • You are generally well enough to have a colonoscopy (ECOG score 0 or 1).
  • If you take medications that slow down your bowels, you stop them at least 3 days before the procedure.
  • You do not have certain serious medical conditions (like recent heart attack, unstable angina, severe lung disease, or bleeding problems).
  • You have not had parts of your stomach, small intestine, or colon removed (except appendix removal).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07127354Recruiting· Phase 4
GLP-1 medications and colonoscopy prep quality

This study tests whether a special bowel preparation plan works better for people taking GLP-1 or GIP medications (like Ozempic, Mounjaro) before a colonoscopy. It aims to improve the quality of the bowel cleaning so doctors can see the colon more clearly.

Cleveland, Florida
NCT07736911Recruiting· Phase 3
Should you pause your diabetes medication before a stomach scope?

This trial is testing whether stopping GLP-1 receptor agonists or tirzepatide one week before an upper endoscopy (a scope that looks at your stomach and esophagus) is safe and effective. It's designed for people who are already taking these medications and have an upcoming procedure.

New Taipei City, Taiwan
NCT07209046Not yet recruiting
Probiotic for weight after stopping GLP-1 medication

This trial tests whether a probiotic supplement called UltraFlora Triplebiotic can help prevent weight gain after stopping a GLP-1 medication. If you recently stopped a GLP-1 drug, this study may help you maintain your weight.

NCT06734312Recruiting
Stomach procedure to maintain weight loss after GLP-1s

This study is for people who have lost weight using semaglutide or tirzepatide and are stopping that medication. It tests a stomach procedure (called mucosal ablation) to see if it can help you keep the weight off after stopping the drug.

Cary, North Carolina
NCT07130396Not yet recruiting
Multivitamin and probiotic for gut health on GLP-1 meds

This study tests whether taking a special multivitamin and probiotic can improve gut health in people who are already taking a GLP-1 medication. It lasts about 12 weeks and involves taking the supplements daily.

NCT07276763Not yet recruiting
Stopping GLP-1 drugs before endoscopy to prevent stomach delay

This study looks at whether pausing GLP-1 agonist medications (like Ozempic or Trulicity) for two weeks before an upper endoscopy can reduce the chance of food staying in the stomach during the procedure. It may help people who take these diabetes medicines and need a routine endoscopy.

Shanghai, Shanghai Municipality

Hear when a new GLP-1 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.